June 1-6, 2008 - Algarve, Portugal

Editors:   Barry C. Buckland, Merck & Co., Inc.
  John G. Auniņš, Merck & Co., Inc.
  Paula Marques Alves, ITQB/IBET
  Kathrin U. Jansen, Wyeth Vaccine Research

The articles for these proceedings are not peer-reviewed.

Follow

Articles from 2008

PDF

VACCINE TECHNOLOGY II: Conference Program, Barry C. Buckland, John G. Auniņš, Paula Marques Alves, and Kathrin U. Jansen

PDF

Quality Issues: The Good-Enough Vaccine, Philip Minor

PDF

Towards a Therapeutic Hepatitis C Vaccine – a Preclinical and Clinical Learning Curve, Alexander von Gabain

PDF

VEEV Replicon-Based Vaccines Used in Heterologous Prime Boost Strategies Induce Lifelong Protection Against Prostate Cancer and Therapy of Cervical Cancer in Mice and Robust Cell-Mediated Immunity in Rhesus macaques, W. Martin Kast

PDF

FluBlok, A High Dose Recombinant Hemagglutinin Influenza Vaccine, Manon Cox

PDF

Challenges and Solutions for the Next Generation of Vaccines: Development of Cell Culture-based Live Attenuated Influenza Vaccine, Jonathan Liu, Luis Maranga, Sachin Mani, and Richard Schwartz

PDF

Analytical and Manufacturing Challenges in Preparation of Bacterial Polysaccharide Conjugates, Carl Frasch

PDF

Development of Validated Assays for Measuring the Human Antibody Response to Polysaccharide Conjugate Vaccines, Helena Käyhty

PDF

Development of Vaxfectin®-adjuvanted DNA Vaccines, Alain Rolland

PDF

Well-Characterized Adenoviral Vector-Based Vaccines: Are We There Yet?, Katey Einterz Owen

PDF

Focus on Aggregation: Causes, Impact & Characterization, John Philo

PDF

RSV Vaccine Using Recombinant F protein?, Sophie Nallet

PDF

A Selective Recovery Methodology for the Primary Purification of Lipid Envelope Virus-Like Particles from S. cerevisiae, Gaik Sui Kee, Hari Pujar, and Nigel Titchener-Hooker

PDF

Trouble-Shooting Fermentation and Primary Recovery Manufacturing Issues in Order to Optimize Antigen Expression for the Vaccine Business, Tim Lee

PDF

Vaccine Development for Developing Countries – Regulatory Approach in the European Union, Manfred G. Haase

PDF

Developing Vaccines for Neglected Diseases, Douglas Holtzman

PDF

Challenge of Filing 4 New Vaccines at Once – Lessons Learned, Keith Chirgwin

PDF

Process Intensification for Large Scale Manufacturing Issues, J.C. Drugmand, N. Havelange, N. Alaoui, and J. Castillo

PDF

Emerging Diseases, Zoonoses and Vaccines to Control Them, Paul-Pierre Pastoret

PDF

Vaccine Technology II: Abstracts of Oral Presentations, The Editors

PDF

Vaccine Technology II: Abstracts of Poster Presentations, The Editors